Vanderbilt-Ingram Cancer Center

A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy – and may offer a way to further refine personalized cancer treatments. The approach, developed by investigators at Vanderbilt-Ingram Cancer Center, shows that erlotinib – a targeted therapy that acts on a growth factor receptor mutated in [...]

Dr. Jordan Berlin, clinical director of the gastrointestinal oncology program at Vanderbilt-Ingram Cancer Center, discusses current research efforts on pancreatic cancer as well as open clinical trials at Vanderbilt-Ingram.

As a clinical trials nurse Wendy Cooper, B.S.N., R.N., has a ringside seat to the bench-to-bedside progress of cancer research. “We have brilliant minds who work on one pathway or one piece of the puzzle for their entire career,” said Cooper, the assistant director of clinical research operations for the Clinical Trials Shared Resource (CTSR) [...]

While one in three Americans will develop some form of cancer according to the National Cancer Institute’s Center to Reduce Cancer Health Disparities, it is the number one cause of death for many racial and ethnic minorities in the U.S.  Health disparities have been defined by the differences in health conditions among specific populations, and [...]

Cousins with melanoma caused by the same genetic mutation enroll in a randomized clinical trial of a promising experimental drug that targets the mutation. Randomly assigned to different groups, one young man gets the new drug, experiences dramatic shrinkage of his tumors and is alive nine months later, while his cousin receives current therapy — [...]

Vanderbilt cancer experts are coordinating with pancreatic cancer awareness groups throughout November to shine a spotlight on this devastating disease. Nov. 4-7, Tennessee’s state Capitol will be lit with a purple glow as part of the “Paint Nashville Purple” event launched by a support organization called Linda’s Hope. Vanderbilt physicians who treat pancreatic cancer will [...]

The Vanderbilt-Ingram Cancer Center is joining with national and local partners to offer AWARE for All – Nashville Clinical Research Education Day on Saturday, Feb. 20. This event, which is free and open to the public, is believed to be the first community-wide event designed to inform Middle Tennessee residents about the important role that they can play in making medical advances possible and to celebrate the contributions of clinical research participants in moving science forward.

The Vanderbilt-Ingram Cancer Center is joining with national and local partners to offer AWARE for All – Nashville Clinical Research Education Day on Saturday, Feb. 20.

This event, which is free and open to the public, is believed to be the first community-wide event designed to inform Middle Tennessee residents about the important role that they can play in making medical advances possible and to celebrate the contributions of clinical research participants in moving science forward.